Showing results (21-30 of 29) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Synapse (New York, N.Y.)|September 1, 1996
Iodolisuride and iodobenzamide, two ligands for SPECT exploration of the dopaminergic D2 receptors: a comparative studyC Pellevoisin, D Guilloteau, J L Baulieu, et al.Toxicological European Research. Recherche Europeenne En Toxicologie|January 1, 1981
[Thermal degradation of tributyltin oxide and pulmonary toxicity of its combustion products in mice and guinea pigs]R Truhaut, J P Anger, F Anger, et al.European Journal of Cancer (Oxford, England : 1990)|April 1, 1990
Immunoscintigraphy of Hodgkin's disease: in vivo use of radiolabelled monoclonal antibodies derived from Hodgkin cell linesP Carde, L Da Costa, L Manil, et al.Annales De Medecine Interne|January 1, 1989
[Initial results in man of immunolymphoscintigraphy of cancer of the prostate]P Teillac, M Leroy, J D Rain, et al.Cancer Research|June 1, 1989
Biodistribution of indium-111-labeled OC 125 monoclonal antibody intraperitoneally injected into patients operated on for ovarian carcinomasJ F Chatal, J C Saccavini, J F Gestin, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 1, 1987
Immunoscintigraphy of recurrences of gynecologic carcinomasJ F Chatal, P Fumoleau, J C Saccavini, et al.International Journal of Cancer|February 18, 1998
Phase-I/II radio-immunotherapy study with Iodine-131-labeled anti-CEA monoclonal antibody F6 F(ab')2 in patients with non-resectable liver metastases from colorectal cancerM Ychou, A Pelegrin, P Faurous, et al.European Journal of Nuclear Medicine|January 1, 1990
Multi-centre immunoscintigraphic study using indium-111-labelled CEA-specific and/or 19-9 monoclonal antibody F(ab')2 fragmentsA Chetanneau, R P Baum, P A Lehur, et al.Bulletin Du Cancer|December 23, 2000
[Immunotargeting of tumors: state of the art and prospects in 2000]A Pèlegrin, F Xavier, J Barbet, et al.Pageof 3